Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
International Journal of Clinical & Laboratory Research|January 1, 1992
Bleeding time and antiplatelet agents in normal volunteersE M Pogliani, C Fowst, R Bregani, et al.
The Journal of International Medical Research|January 1, 1989
Effects of a defibrotide-heparin combination on some measures of haemostasis in healthy volunteersE M Pogliani, M Salvatore, C Fowst, et al.
Acta Haematologica|January 1, 1989
Platelet dysfunction in acute megakaryoblastic leukemiaE M Pogliani, M Colombi, E Cofrancesco, et al.
British Journal of Cancer|October 17, 2003
Brostallicin (PNU-166196)--a new DNA minor groove binder that retains sensitivity in DNA mismatch repair-deficient tumour cellsA Fedier, C Fowst, J Tursi, et al.
Tumori|December 31, 1988
CNS metastasis in ovarian cancer with microangiopathic hemolytic anemia associated with diffuse intravascular coagulationE M Pogliani, C Fowst, P Maffé, et al.
European Journal of Cancer (Oxford, England : 1990)|April 23, 2003
Blood glutathione as a surrogate marker of cancer tissue glutathione S-transferase activity in non-small cell lung cancer and squamous cell carcinoma of the head and neckE Ferruzzi, R Franceschini, G Cazzolato, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Pilot study of subcutaneous recombinant human interleukin 12 in metastatic melanomaE Bajetta, M Del Vecchio, R Mortarini, et al.
European Journal of Cancer (Oxford, England : 1990)|November 1, 2000
Exemestane improves survival compared with megoestrol acetate in postmenopausal patients with advanced breast cancer who have failed on tamoxifen. results Of a double-blind randomised phase III trialM Kaufmann, E Bajetta, L Y Dirix, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2000
Activity of exemestane in metastatic breast cancer after failure of nonsteroidal aromatase inhibitors: a phase II trialP E Lønning, E Bajetta, R Murray, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2000
Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer: results of a phase III randomized double-blind trial. The Exemestane Study GroupM Kaufmann, E Bajetta, L Y Dirix, et al.
Pageof 2